[Reversal of hepatorenal syndrome after liver transplantation. Considerations about 3 patients].
Hepatorenal syndrome was observed in 25% of the patients with end stage liver disease. In this situation they stayed longer time in intensive unit treatment, hemodialysis. This evolution was observed in 67% of them with this complication after surgery. In this report we describe three patients with hepatorenal syndrome reversible after liver transplant. We define the form of management of these patients after surgery, regard treatment with cyclosporine A, only 72 h after surgery, without administration of aminoglycosides and amphoterycin. This good evaluation also depends of absence of arterial hypotension or infection episodes during and after surgery. It also depends of the good conditions of the implanted liver.
de Oliveira e Silva
A
A
Centro Terapêutico Especializado em Figado-CETEFI, Hospital da Beneficência Portuguesa de São Palo.
de Melo
C R
CR
dos Santos
T E
TE
Cardoso
E S
ES
Copstein
J L
JL
Santos Júnior
E D
ED
meniconi
M T
MT
Abensur
H
H
Noronha
I L
IL
Araújo
M R
MR
Romão Júnior
J E
JE
D'Albuquerque
L A
LA
D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006530:Hepatorenal Syndrome / Q000097:blood / Q000209:etiology / Q000601:surgery*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care
D016572:Cyclosporine
Reversão da síndrome hepatorrenal após transplante de fígado. Considerações sobre três pacientes.